Serina Therapeutics Valuation
| SER Stock | 4.79 0.64 15.42% |
At this time, the company appears to be fairly valued. Serina Therapeutics has a current Real Value of USD4.69 per share. The regular price of the company is USD4.79. Our model measures the value of Serina Therapeutics from inspecting the company fundamentals such as Number Of Shares Shorted of 27.52 K, current valuation of 62.84 M, and Return On Asset of -0.45 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Serina Therapeutics' valuation include:
Enterprise Value 62.8 M | Enterprise Value Ebitda 40.0756 | Price Sales 18.0288 | Trailing PE 46 |
Fairly Valued
Today
Please note that Serina Therapeutics' price fluctuation is very risky at this time. Calculation of the real value of Serina Therapeutics is based on 3 months time horizon. Increasing Serina Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Serina stock is determined by what a typical buyer is willing to pay for full or partial control of Serina Therapeutics. Since Serina Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Serina Stock. However, Serina Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.79 | Real 4.69 | Hype 4.75 | Naive 3.33 |
The intrinsic value of Serina Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Serina Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Serina Therapeutics helps investors to forecast how Serina stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Serina Therapeutics more accurately as focusing exclusively on Serina Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Serina Therapeutics' intrinsic value based on its ongoing forecasts of Serina Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Serina Therapeutics' closest peers.
Serina Therapeutics Cash |
|
Serina Valuation Trend
Serina Therapeutics' real value is important for investors to make better decisions and a more accurate overall view of Serina Therapeutics' financial worth over time. Using both Serina Therapeutics' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Serina Therapeutics Total Value Analysis
Serina Therapeutics is at this time forecasted to have company total value of 62.84 M with market capitalization of 57.2 M, debt of 4.37 M, and cash on hands of . Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Serina Therapeutics fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
62.84 M | 57.2 M | 4.37 M |
Serina Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Serina Therapeutics has an asset utilization ratio of 1.19 percent. This connotes that the Company is making USD0.0119 for each dollar of assets. An increasing asset utilization means that Serina Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Serina Therapeutics Ownership Allocation
The market capitalization of Serina Therapeutics is USD57.2 Million. Serina Therapeutics maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Serina Therapeutics Profitability Analysis
The company reported the last year's revenue of 142 K. Reported Net Loss for the year was (14.8 M) with profit before taxes, overhead, and interest of 0.About Serina Therapeutics Valuation
The stock valuation mechanism determines Serina Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Serina Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Serina Therapeutics. We calculate exposure to Serina Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Serina Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -29 K | -27.6 K | |
| Pretax Profit Margin | (104.30) | (99.09) | |
| Operating Profit Margin | (70.14) | (73.65) | |
| Net Loss | (104.25) | (99.03) | |
| Gross Profit Margin | (0.20) | (0.21) |
Serina Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Serina Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.1 M | |
| Quarterly Earnings Growth Y O Y | 3.568 |
Serina Therapeutics Current Valuation Indicators
Serina Therapeutics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Serina Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Serina Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Serina Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Serina Therapeutics' worth.Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.